Try our beta test site
1296 studies found for:    pruritus
Show Display Options
Rank Status Study
1 Completed Aprepitant in the Management of Biological Therapies-related Severe Pruritus
Condition: ITCH
Interventions: Drug: Aprepitant;   Drug: Prednisone;   Drug: Fexofenadine
2 Completed Gabapentin for Prophylaxis Intrathecal Morphine-Induced Pruritus
Condition: Pruritus
Intervention: Drug: Gabapentin
3 Unknown  Pregabalin for the Treatment of Uremic Pruritus
Condition: Uremic Pruritus
Interventions: Drug: pregabalin 75mg daily for 12 weeks;   Drug: fexofenadine 60 mg daily for 12 weeks;   Drug: placebo
4 Completed Naloxone for the Treatment of Opioid-Induced Pruritus
Condition: Pruritus
Interventions: Drug: Naloxone;   Drug: Saline/Morphine
5 Withdrawn Gabapentin for the Treatment of Pruritus Caused by Burn Injuries in Children
Condition: Pruritus
Intervention: Drug: Gabapentin
6 Completed Efficacy and Safety Study of TRK-820 to Treat Conventional-treatment-resistant Pruritus in Patients Receiving Hemodialysis
Condition: Conventional-treatment-resistant Pruritus in Patients Receiving Hemodialysis
Interventions: Drug: nalfurafine hydrochloride (TRK-820);   Drug: Placebo
7 Completed Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus
Conditions: End Stage Renal Disease;   Pruritus
Interventions: Drug: cromolyn sodium;   Drug: placebo
8 Active, not recruiting Treatment of Uremic Pruritus With PA101B
Condition: Uremic Pruritus
Interventions: Drug: PA101B;   Drug: Placebo
9 Unknown  A Randomized-Withdrawal Phase 3 Study Evaluating the Safety and Efficacy of Oral Nalfurafine HCl (AC-820)in Subjects on Hemodialysis With Uremic Pruritus (Renal Itch)
Condition: Uremic Pruritus
Interventions: Drug: Nalfurafine HCl 2.5 µg;   Drug: Nalfurafine HCl 5.0 µg;   Other: Placebo
10 Completed Study Of Cutaneous Disease Accompanied With Pruritus In Pediatrics
Condition: Pruritus
Intervention: Drug: Cetirizine Dry Syrup
11 Unknown  Efficacy of Pregabalin in the Management of Chronic Uremic Pruritus
Condition: Uremic Pruritus
Interventions: Drug: Pregabalin;   Drug: Placebo
12 Completed Safety and Pharmacokinetics of IV CR845 in Hemodialysis Patients, and Its Efficacy in Patients With Uremic Pruritus
Conditions: Pruritus;   Uremic Pruritus
Interventions: Drug: Part A: Placebo;   Drug: Part A: CR845 0.5 mcg/kg;   Drug: Part A: CR845 1.0 mcg/kg;   Drug: Part A: CR845 2.5 mcg/kg;   Drug: Part B: Placebo;   Drug: Part B: CR845 1.0 mcg/kg
13 Completed
Has Results
Management of Pruritus With Xyzal in Atopic Dermatitis
Conditions: Atopic Dermatitis;   Pruritus
Interventions: Drug: Levocetirizine dihydrochloride (Xyzal);   Drug: placebo
14 Not yet recruiting Central Mechanisms of Chronic Pruritus: Functional and Structural Brain Imaging.
Condition: Itch
Intervention: Other: MRI
15 Withdrawn Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study
Condition: Pruritus
Interventions: Procedure: Biopsy;   Procedure: Blood
16 Completed Evaluating the Effect of Senna in Uremic Pruritus
Conditions: End Stage Renal Disease;   Pruritus
Interventions: Drug: Senna;   Drug: Placebo
17 Completed Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus
Conditions: Uremic Pruritus;   Pruritus
Interventions: Drug: nalbuphine HCl ER tablets 60 mg BID;   Drug: nalbuphine HCl ER tablets 120mg BID;   Drug: Placebo tablets BID
18 Unknown  An Observational Study of Pruritus Amongst Hemodialysis Patients
Conditions: Pruritus;   Kidney Failure, Chronic;   Hemodialysis;   Chronic Disease
Intervention:
19 Recruiting Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Condition: Uremic Pruritus
Interventions: Drug: CR845 0.5 mcg/kg;   Drug: CR845 1 mcg/kg;   Drug: CR845 1.5mcg/kg;   Drug: Placebo
20 Completed Evaluating the Effect of Fumaria Parviflora L. in Uremic Pruritus
Conditions: End-Stage Renal Disease;   Pruritus
Interventions: Drug: Wheat;   Drug: Fumaria

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.